A detailed history of Quest Partners LLC transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 85,341 shares of AVNS stock, worth $972,033. This represents 0.06% of its overall portfolio holdings.

Number of Shares
85,341
Previous 37,091 130.09%
Holding current value
$972,033
Previous $454 Million 117.3%
% of portfolio
0.06%
Previous 0.04%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025

BUY
$9.89 - $12.72 $477,192 - $613,740
48,250 Added 130.09%
85,341 $987 Million
Q2 2025

Jul 31, 2025

BUY
$12.03 - $14.52 $164,714 - $198,807
13,692 Added 58.52%
37,091 $454 Million
Q1 2025

May 14, 2025

BUY
$13.95 - $17.45 $326,416 - $408,312
23,399 New
23,399 $335 Million
Q2 2024

Aug 06, 2024

BUY
$17.85 - $20.42 $397,465 - $454,692
22,267 New
22,267 $444 Million
Q4 2023

Feb 09, 2024

BUY
$17.64 - $22.99 $257,349 - $335,401
14,589 New
14,589 $327 Million

Others Institutions Holding AVNS

About AVANOS MEDICAL, INC.


  • Ticker AVNS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 46,487,000
  • Market Cap $529M
  • Description
  • Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...
More about AVNS
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.